Version 5.4
Mus musculus Protein: Gp2
Summary
InnateDB Protein IDBP-207911.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Gp2
Protein Name glycoprotein 2 (zymogen granule membrane)
Synonyms 2310037I18Rik; AV060639;
Species Mus musculus
Ensembl Protein ENSMUSP00000033255
InnateDB Gene IDBG-207909 (Gp2)
Protein Structure
UniProt Annotation
Function
Subcellular Localization Cell membrane {ECO:0000250}; Lipid-anchor, GPI-anchor {ECO:0000250}. Secreted {ECO:0000250}. Note=Secreted after cleavage.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003823 antigen binding
Biological Process
GO:0002412 antigen transcytosis by M cells in mucosal-associated lymphoid tissue
GO:0045087 innate immune response (InnateDB)
Cellular Component
GO:0005576 extracellular region
GO:0016324 apical plasma membrane
GO:0031225 anchored component of membrane
Protein Structure and Domains
PDB ID MGI:1914383
InterPro IPR001507 Zona pellucida domain
PFAM PF00100
PRINTS PR00023
PIRSF
SMART SM00241
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q9D733
PhosphoSite PhosphoSite-Q9D733
TrEMBL Q9CV52
UniProt Splice Variant
Entrez Gene 67133
UniGene Mm.46403
RefSeq NP_080265
MGI ID
MGI Symbol Gp2
OMIM
CCDS CCDS21779
HPRD
IMGT
EMBL AK009558 AK009661
GenPept BAB26357 BAB26423

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca